It's been a crazy time for the interface of science and sex (which I tend to file under the label "Cupid's Chemistry" -- the preliminary title for the translation project that ended up being published as Lust and Love: is it more than chemistry?).
First everybody went batty over the fruity practices of fruit bats. Clearly, everybody else angling for next year's IgNobel prize in biology can stop trying now. There's not a chance in hell you can beat that.
Then "21st century Moll Flanders," blogger, and bestselling author Belle de Jour turns out to be a working ... scientist. On hearing the news I went looking for my copy of her first book (one of the treasures I found at Oxfam), and found I had already put it on my "Cupid's chemistry" shelf. Very prescient. Also found out she has just published her fourth one, will need catch up with the reading ... Which shouldn't be a problem, as she writes extremely well, for a scientist.
And now we have a "female viagra" which turns out not to be acting on the blood flow, but on the brain, so nothing like viagra really, except that it helps getting some action going. Flibanserin turns out to be a failed anti-depressant developed by Boehringer Ingelheim, which now was tested successfully for treatment of "hypoactive sexual desire disorder". Which leaves me wondering who (men or women) defines where the normal ends and the hypo starts. But anyhow, the drug should be around soonish. Watch out for the spams offering it cheaper.
PS -- re. comments: I'm sorry I have now been forced to add anti-spam measures to the comment handling, as the blog is attracting an increasing flow of spam comments. Word recognition will be required for all comments, and on older posts there will also be a moderation step.
And if you see any dodgy comments, _don't_ click on the links!